MBX Biosciences, Inc. (MBX) (CIK 0001776111) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-25-308171
- Form
- CORRESP
- Filer
- MBX Biosciences, Inc. (MBX) (CIK 0001776111)
- CIK
- 0001776111
- Ticker
- MBX
- Filed
- 2025-12-04
- SIC industry
- 2834
- HQ
- Carmel, IN
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1776111/000119312525308171/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer